Direct renin inhibition: An update

Current Hypertension Reports

Volumn 11, Issue 6, 2009, Pages 456-462

  Gradman, Alan H ^a   Pinto, Rekha ^b  

^a TEMPLE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ALISKIREN PLUS HYDROCHLOROTHIAZIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN; PLACEBO; PRORENIN RECEPTOR; RAMIPRIL; RENIN; VALSARTAN;

ANGIONEUROTIC EDEMA; AREA UNDER THE CURVE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MONOTHERAPY; NONHUMAN; PLASMA RENIN ACTIVITY; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; FUMARATES; HUMANS; HYPERTENSION; RATS; RENIN;

EID: 72549102335     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0077-7     Document Type: Review

References (26)

1. B. Dahlöf D.R. Anderson V. Arora, et al. 2007 Aliskiren, a direct renin inhibitor, provides antihypertensive efficacy and excellent tolerability independent of age or gender in patients with hypertension [abstract] J Clin Hypertens 9 SupplA A157
2. S. Oparil S.A. Yarows S. Patel, et al. 2007 Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial Lancet 370 221 229 10.1016/S0140-6736(07)61124-6 1:CAS:528:DC%2BD2sXnvF2gsrc%3D 17658393 (Pubitemid 47069535)
3. A.H. Gradman R.E. Schmieder R.L. Lins, et al. 2004 Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an AT1-receptor blocker in hypertensive patients [abstract] Am J Hypertens 17 S108 10.1016/j.amjhyper.2004.03.279
4. A. Stanton C. Jensen J. Nussberger E. O'Brien 2003 Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren Hypertension 42 1137 1143 10.1161/01.HYP.0000101688.17370.87 1:CAS:528:DC%2BD3sXpsVGisrg%3D 14597641 (Pubitemid 37549068)
5. R.E. Schmieder T. Philipp J. Guerediaga, et al. 2009 Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide Circulation 119 417 425 10.1161/CIRCULATIONAHA.107.750745 1:CAS:528:DC%2BD1MXpt1Cmsg%3D%3D 19139391
6. European Medicines Agency: European Medicines Agency recommends new contraindication and warning for Rasilez and other aliskiren medicines [press release]. London: February 19, 2009. Available at http://www.emea.europa.eu/ pdfs/human/press/pr/8952309en.pdf. Accessed September 17, 2009.
7. J. Pool A. Gradman R. Kolloch, et al. 2006 Aliskiren, a novel renin inhibitor, provides long-term suppression of the renin system, when used alone or in combination with hydrochlorothiazide in the treatment of hypertension Eur Heart J 119 suppl27 790
8. Palatini P, Jung W, Shlyakhto E, et al.: Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study. J Hum Hypertens 2009 May 21 (Epub ahead of print).
9. B.H. Oh J. Mitchell J.R. Herron, et al. 2007 Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension J Am Coll Cardiol 49 1157 1163 10.1016/j.jacc.2006.11.032 1:CAS:528:DC%2BD2sXjtVagurk%3D 17367658 (Pubitemid 46400330)
10. A. Villamil S.G. Chrysant D. Calhoun, et al. 2007 Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide J Hypertens 25 217 226 10.1097/HJH.0b013e3280103a6b 1:CAS:528:DC%2BD28Xht1OhtrnM 17143194 (Pubitemid 44885684)
11. Y. Uresin A. Taylor C. Kilo, et al. 2007 Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension J Renin Angiotensin Aldosterone Syst 8 190 198 10.3317/jraas.2007.028 1:CAS:528:DC%2BD1cXhs1yqsLY%3D 18205098 (Pubitemid 351166266)
12. R. Dietz R. Dechend C.M. Yu, et al. 2008 Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension J Renin Angiotensin Aldosterone Syst 9 163 175 10.1177/ 1470320308096411 1:CAS:528:DC%2BD1cXhsFCku7jI 18957387
13. J.E. Sealey J.H. Laragh 2007 Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness Am J Hypertens 20 587 597 10.1016/j.amjhyper.2007.04.001 1:CAS:528: DC%2BD2sXkvF2jt7k%3D 17485026 (Pubitemid 46678721)
14. D.J. Campbell 2008 Interpretation of plasma renin concentration in patients receiving aliskiren therapy Hypertension 51 15 18 10.1161/ HYPERTENSIONAHA.107.101287 1:CAS:528:DC%2BD2sXhsVagurbL 17984367 (Pubitemid 350307093)
15. A.H. Danser A. Charney D.L. Feldman, et al. 2008 The renin rise with aliskiren: it's simply stoichiometry Hypertension 51 e27 e28 10.1161/HYPERTENSIONAHA.108.109967 1:CAS:528:DC%2BD1cXmsFamtbg%3D 18285609 (Pubitemid 351654714)
16. A. Stanton A.H. Gradman R. Schmieder, et al. 2009 Aliskiren does not cause paradoxical rises in blood pressure [abstract P-56] J Clin Hypertens 11s1 A39
17. D.J. Kelly Y. Zhang G. Moe, et al. 2007 Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats Diabetologia 50 2398 2404 10.1007/s00125-007-0795-9 1:CAS:528: DC%2BD2sXhtFSlsL%2FI 17828524 (Pubitemid 47512400)
18. D.L. Feldman L. Jin H. Xuan, et al. 2008 Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats Hypertension 52 130 136 10.1161/HYPERTENSIONAHA.107.108845 1:CAS:528:DC%2BD1cXntVaisL0%3D 18490518
19. N.D. Fisher A.H. Jan Danser J. Nussberger, et al. 2008 Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans Circulation 117 3199 3205 10.1161/CIRCULATIONAHA.108.767202 1:CAS:528: DC%2BD1cXnt1ehs70%3D 18559696
20. G. Nguyen F. Delarue C. Burckle, et al. 2002 Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin J Clin Invest 109 1417 1427 1:CAS:528:DC%2BD38XktlWlu78%3D 12045255
21. D. de Zeeuw G. Remuzzi H.H. Parving, et al. 2004 Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL Kidney Int 65 2309 2320 10.1111/j.1523-1755.2004.00653.x 15149345 (Pubitemid 38670018)
22. H.H. Parving F. Persson J.B. Lewis AVOID Study Investigators, et al. 2008 Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2433 2446 10.1056/NEJMoa0708379 1:CAS:528:DC%2BD1cXmvFKmtLY%3D 18525041 (Pubitemid 351793017)
23. S.D. Solomon E. Appelbaum W. A. i. L. V. H. Manning, et al. 2009 Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy Circulation 119 530 537 10.1161/CIRCULATIONAHA.108. 826214 1:CAS:528:DC%2BD1MXpt1eksA%3D%3D 19153265
24. D. Westermann A. Riad O. Lettau, et al. 2008 Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure Hypertension 52 1068 1075 10.1161/HYPERTENSIONAHA.108.116350 1:CAS:528:DC%2BD1cXhsVWrt7vN 18955663
25. R. Latini S. Masson I. Anand, et al. 2004 The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 292 299 10.1016/j.ehj.2003.10.030 1:CAS:528:DC%2BD2cXhsV2gsr8%3D 14984917 (Pubitemid 38295437)
26. J.J.V. McMurray B. Pitt R. f. t. A. O. o. H. F. T. Latini, et al. 2008 Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure Circ Heart Fail 1 17 24 10.1161/CIRCHEARTFAILURE.107. 740704 1:CAS:528:DC%2BD1cXosFGnsLY%3D 19808266